Erik Haas is a member of the firm's litigation department and Co-Chair of the firm's Structured Finance Litigation Team, concentrating his practice in complex commercial litigation. In addition to a wide range of general commercial disputes, the substantive areas of his practice include (i) complex securities and securitizations, (ii) pricing and reimbursement fraud and False Claims Act matters, (iii) shareholder class actions, (iv) antitrust, (v) products liability, and (vi) intellectual property litigation, including false advertising, patents and trademarks. Mr. Haas joined the firm in 1993 upon his graduation from New York University School of Law where he was presented with American Jurisprudence Awards. Before attending law school, he spent three years with Arthur Andersen & Company, where he focused on structured finance and securitization transactions, and secured his CPA license.
Mr. Haas is recognized by Chambers USA in the area of Litigation: General Commercial. The guide notes that he received “strong praise for his ‘good courtroom manner and terrific client service.’ He is ‘effective across the board’ in a range of securities and commercial litigation.” Euromoney Institutional Investor PLC’s Benchmark: America's Leading Litigation Firms and Attorneys lists Mr. Haas as a "Litigation Star" for New York.
General Commercial Litigation
Represented domestic and foreign clients in high-stakes and complex commercial disputes, involving a broad range of substantive matters, from joint venture disputes to common law fraud claims.
Complex Securities Litigation
Representing financial guarantors in actions against sponsors and originators of mortgage-backed securities, and foreign corporations in complex derivative disputes with domestic investment banks.
Pricing and Reimbursement Fraud and False Claims Act Matters
Representing major institutions in connection with investigations and litigations brought under unfair and deceptive act statutes and the False Claims Act arising from allegations of pricing and reimbursement fraud.
Shareholder Class Actions
Defending corporations against shareholder class action claims brought in state and federal court. Also defended brokerage houses against securities fraud claims in NASD and NYSE arbitrations.
Recently secured a $200 million settlement in an antitrust litigation brought by large pharmaceutical client.
Represented consumer product companies in false advertising actions brought in federal and state courts. Also recently represented the Federal Deposit Insurance Corporation in its successful suits against banks and credit card companies involved in deceptive credit card offerings.
Defended pharmaceutical and product manufacturers against products liability claims in federal and state courts.
Represented a Fortune 50 pharmaceutical company in numerous infringement actions involving patents on mechanical devices, and in dispute involving license on patent covering a drug.
Trademark and Trade Dress
Brought trademark and trade dress claims to protect the intellectual property rights of the firm's clients.
Negotiated and drafted complex international joint venture and commercial transaction agreements for foreign and domestic clients.